Biotricity (BTCY) Stock Statistics & Valuation Metrics

Biotricity has a market cap or net worth of $12.08M. The enterprise value is $34.11M.

Biotricity has 26,567,768 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biotricity’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 100.16%.

The current PE Ratio of Biotricity is ―. Biotricity’s PEG ratio is 0.01.

In the last 12 months, Biotricity had revenue of 13.79M and earned -8.42M in profits. Earnings per share was -0.56.

In the last 12 months, operating cash flow was -2.38M and capital expenditures 0.00, giving a free cash flow of -2.38M billion.

Biotricity pays an annual dividend of ―, resulting in a dividend yield of ―

Biotricity upcoming earnings date is Aug 18, 2025, Before Open (Confirmed).

Biotricity as a current ratio of 0.22, with Debt / Equity ratio of -86.93%

In the past 12 months, Biotricity has paid 0.00 in taxes.

Biotricity EV to EBITDA ratio is -10.28, with an EV/FCF ratio of -13.88.

Biotricity has $365.14K in cash and marketable securities with $26.09M in debt, giving a net cash position of $25.73M billion.

Gross margin is 76.61%, with operating margin of -17.76%, and net profit margin of -61.07%.

The average price target for Biotricity is ―, which is 11.43% higher than the current price. The consensus rating is Hold